Sistema Asia Fund marks second exit with the sale of Netmeds

The deal sees the venture capital fund reap attractive returns within three years of its investment into the e-pharmacy startup

Sistema Asia Fund announced that it has sold its stake in Netmeds, one of India’s leading online pharmaceutical marketplaces. The deal is part of the transaction in which Reliance Retail Ventures Limited has acquired the e-pharmacy startup.

Sistema Asia Fund focuses on investing in technology-enabled, consumer and business-oriented startups in India and Southeast Asia - namely those with exceptional teams, global scaling potential and solid revenue streams.

Sistema Asia Fund first invested in Netmeds in 2017 and this exit will gather attractive returns for the venture capital fund as the online pharmaceutical startup grew four times its size over the past three years. The deal also marks Sistema Asia Fund’s second exit and monetization, after selling its stake in Qwikcilver in March 2019.

“Since investing in Netmeds in 2017, Sistema Asia Fund has strengthened the startup’s leadership position in the burgeoning online pharmacy market by supporting the enhancement of supply chain and distribution network, as well as exploring the viability of its international expansion. Also, Netmeds’ rapid growth over the last few years underlines our strategy of investing in companies with strong scaling potential and solid revenue streams,” said Andrey Terebenin, Managing Partner, Sistema Asia Capital.

Andrey added, “Reliance’s backing of Netmeds is a strong endorsement of our investment philosophy, which is to optimize our investors' money into promising projects in India’s fast-growing technology market. We are confident that Reliance’s entry will accelerate Netmeds’ growth and help the startup establish itself as the leader in the online pharmacy sector. We want to wish Netmeds continued successful growth and realize its fullest potential with Reliance.”

Founded by Pradeep Dadha in 2010, Netmeds is one of India's leading e-pharmacy brand driven to revolutionize India’s healthcare sector. Currently, the startup serves over 4 million customers nationwide, enabling them to purchase medicine online, sign up for monthly pharmaceutical subscriptions, book lab tests, organize health checkups and consult verified doctors online. The company’s services saw an especially high demand during the COVID-19 pandemic, such as their delivery service which supplied medicine to patients in over 14,000 regions across India.

Currently, following its exit from Netmeds, Sistema Asia Fund is an investor in eight companies, including Licious (a direct-to-consumer meat and seafood brand), Rebel Foods (a multi-brand full stack online food-on-demand app), Uniphore (a conversational AI technology company), Lendingkart Technologies (an online financing company assisting SMEs with financing working capital for SMEs), HealthifyMe (a health and fitness mobile app), Seclore (an enterprise data security company) and Kissht (a consumer lending FinTech platform).

Sistema companies act to help market withstand COVID-19 outbreak
20 March 2020
Ozon wraps up 2019 with record GMV growth, 6,500 marketplace partners, 16,000 pickup points and new services
27 February 2020
Sistema companies Business Nedvizhimost and Cosmos Hotel Group join forces to revamp Dom Svyazi building in the heart of Moscow
2 February 2020
Segezha Group proves sustainable business means successful business
27 January 2020

Subscribe

Selected category
By clicking on the «Subscribe» button, you agree to the personal data processing policy.